| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/04/2015 | CN104324007A 一种天然重组纳米脂质载体制备技术与应用 A natural recombinant preparation and application of nanotechnology lipid carrier |
| 02/04/2015 | CN104324005A 一种争光霉素脂质微泡及其制备方法 One kind of bleomycin lipid microbubbles and preparation method |
| 02/04/2015 | CN104324003A 阿糖胞苷脂质体组合药物及其大工业化生产工艺和用途 Cytarabine liposome drug combination and large industrial production processes and uses |
| 02/04/2015 | CN104324001A 米托蒽醌脂质体组合药物及其大工业化生产工艺和用途 Liposomal mitoxantrone combination of drugs and large industrial production processes and uses |
| 02/04/2015 | CN104324000A 依托泊苷脂质体组合药物及其大工业化生产工艺和用途 Etoposide combination of drugs and large liposomes industrialized production process and use |
| 02/04/2015 | CN104323993A 盐酸昂丹司琼脂质体组合药物及其大工业化生产工艺和用途 Ondansetron Hydrochloride drug combination agar plastid and large industrial production processes and uses |
| 02/04/2015 | CN104323990A 一种紫杉烷衍生物tm-2的脂质微球注射液及其制备方法 A taxane derivative of lipid microspheres tm-2 of the injection and its preparation method |
| 02/04/2015 | CN104323985A 一种基于碳材料的多糖类口服结肠靶向水凝胶的制备方法与应用 A preparation method and application of oral polysaccharide hydrogel colon targeting carbon-based materials |
| 02/04/2015 | CN103613529B 吡咯类衍生物及其制备方法和应用 Azole derivative and its preparation method and application |
| 02/04/2015 | CN103435572B 噻唑并环己烷类化合物、其制备方法和抗肿瘤用途 Thiazolo cyclohexane compounds, their preparation and use of anti-tumor |
| 02/04/2015 | CN103396417B 新型羟肟酸衍生物及其医疗应用 Novel hydroxamic acid derivative and medical applications |
| 02/04/2015 | CN103304513B 一类1,2-苯并噻嗪类化合物、制备方法及其应用 A class benzothiazine compounds, preparation method and application |
| 02/04/2015 | CN103285047B 长根菇蛋白质提取物及其抗肿瘤的应用 Application Oudemanciella protein extracts and anti-tumor |
| 02/04/2015 | CN103285046B 毛木耳蛋白质提取物及其抗肿瘤的应用 Application Auricularia protein extracts and anti-tumor |
| 02/04/2015 | CN103211853B 一种具有多酚氧化酶抑制活性的蓝莓叶提取物 A kind of polyphenol oxidase inhibitory activity of blueberry leaf extract |
| 02/04/2015 | CN103204997B 一种光动力治疗用聚乳酸/聚乙二醇生物杂化材料的制备方法 Photodynamic therapy using a polylactic acid / polyethylene glycol method for preparing hybrid biological material |
| 02/04/2015 | CN103156884B 精浆的用途 Seminal purpose |
| 02/04/2015 | CN103142653B 一种治疗皮肤癌组合药物及其制备方法 A treatment for skin cancer drug combination and its preparation method |
| 02/04/2015 | CN103099826B 一种从南方红豆杉叶中提取紫杉黄酮的方法 A method to extract from yew Taxus chinensis leaves flavonoids |
| 02/04/2015 | CN103088029B 一种双增强子甲胎蛋白重组启动子及其应用 A dual enhancer promoter and its application of recombinant alpha-fetoprotein |
| 02/04/2015 | CN103087192B 抗-kdr抗体和使用方法 Anti -kdr antibodies and methods of use |
| 02/04/2015 | CN102964461B 一种提高石斛生物活性多糖溶出率的生物酶辅助提取方法 An increase Dendrobium enzyme dissolution rate bioactive polysaccharide assisted extraction method |
| 02/04/2015 | CN102924550B 地西他滨5'-o-氨基酸酯类前药及其制备方法 Decitabine 5'-o- amino acid ester prodrugs of its preparation method |
| 02/04/2015 | CN102872017B 6-(4-(二氟甲氧基)-3-甲氧基苯基)哒嗪-3(2h)-酮在制备抗肿瘤药物中的用途 6- (4- (difluoromethoxy) -3-methoxyphenyl) pyridazin -3 (2h) - one for the preparation of antitumor drugs |
| 02/04/2015 | CN102844303B 制备氘代二苯基脲的方法 Preparation of deuterated diphenylurea method |
| 02/04/2015 | CN102827116B 含α-芳基-γ-亚甲基丁烯内酯类化合物及其合成方法和用途 Containing α- aryl -γ- methylene within butene esters and synthetic method and use |
| 02/04/2015 | CN102803222B 一种氘代的ω-二苯基脲的合成及生产的方法和工艺 One kind of deuterated ω- diphenyl urea and production methods and processes |
| 02/04/2015 | CN102775457B 核苷连萘二酰亚胺衍生物及其合成方法和用途 Nucleoside even naphthalene diimide derivatives and synthetic method and use |
| 02/04/2015 | CN102772429B 一种能杀伤放化疗耐药肿瘤细胞和肿瘤干细胞的癌症治疗药物 One kind of energy killing chemotherapy-resistant tumor cells and cancer stem cells in cancer therapy |
| 02/04/2015 | CN102746258B 卡巴他赛的结晶形式及其制备方法 He crystalline form Kabbah race and its preparation method |
| 02/04/2015 | CN102558049B 一类双香豆素类化合物及其制备方法和用途 A class of two coumarins their preparation and use |
| 02/04/2015 | CN102325752B 咔唑和咔啉激酶抑制剂 Carbazole and carboline kinase inhibitor |
| 02/04/2015 | CN102159207B 取代的吡咯烷-2-甲酰胺类 Substituted pyrrolidine-2-carboxamide |
| 02/04/2015 | CN101981033B 用作激酶抑制剂的取代的咪唑并哒嗪化合物 Are useful as kinase inhibitors substituted imidazo pyridazine compound |
| 02/03/2015 | US8946443 Cyclopropanecarboxylic acid derivative |
| 02/03/2015 | US8946386 Proteins expressed in NK cells |
| 02/03/2015 | US8946291 Compositions and methods for treating pigmentary conditions and melanoma |
| 02/03/2015 | US8946190 Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer |
| 02/03/2015 | US8946171 Immunization of an individual against carcinomas and the preliminary stages thereof |
| 02/03/2015 | US8946168 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 02/03/2015 | US8946167 Pharmaceutical compositions containing plasma protein |
| 02/03/2015 | US8946161 Method of treatment using stable liquid formulation of G-CSF |
| 02/03/2015 | US8946159 Administration of an antagonist of α5β1 for anti-angiogenesis and cancer treatment |
| 02/03/2015 | US8946156 Albumin Fusion Proteins |
| 02/03/2015 | US8945583 GLUT-1 as a receptor for HTLV envelopes and its uses |
| 02/03/2015 | CA2814907C Crystalline form of 13-[(n-tert-butoxycarbonyl)-2'-o-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin iii |
| 02/03/2015 | CA2812929C Compositions and methods for treating hyperproliferative disorders |
| 02/03/2015 | CA2780547C Spiro-oxindole mdm2 antagonists |
| 02/03/2015 | CA2775793C Siglec 15 antibodies in treating bone loss-related disease |
| 02/03/2015 | CA2768008C Clostridial neurotoxins for treating uterine disorders |
| 02/03/2015 | CA2751263C Novel saponin compounds, methods of preparation thereof, use thereof and pharmaceutical compositions |
| 02/03/2015 | CA2698173C Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof |
| 02/03/2015 | CA2632552C Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and their use |
| 02/03/2015 | CA2631775C Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 02/03/2015 | CA2631082C Oncogenic ras-specific cytotoxic compound and methods of use thereof |
| 02/03/2015 | CA2612338C Sphingosine kinase inhibitors |
| 02/03/2015 | CA2610647C Novel inhibitors of pyruvate kinase as therapeutic agents for cancer |
| 02/03/2015 | CA2608463C Compounds, compositions containing such compounds, and methods of treatment of metastatic melanoma and other cancers |
| 02/03/2015 | CA2588923C Compositions and methods for treating neoplastic diseases |
| 01/29/2015 | WO2015013675A1 Spherical nucleic acid-based constructs as immunoregulatory agents |
| 01/29/2015 | WO2015013665A1 Clinical multimodality-tools for pre-and intraoperative insulinoma diagnostics |
| 01/29/2015 | WO2015013565A1 Platinum derivatives for hydrophobic formulations |
| 01/29/2015 | WO2015013341A1 Compositions, methods and kits for diagnosing and treating cd206 expressing cell-related disorders |
| 01/29/2015 | WO2015012298A1 Quinoline derivative |
| 01/29/2015 | WO2015012175A1 Diagnostic drug and therapeutic drug for small cell lung cancer |
| 01/29/2015 | WO2015012149A1 Novel triazine derivative |
| 01/29/2015 | WO2015011711A1 Short peptides derived from vdac1, compositions and methods of use thereof |
| 01/29/2015 | WO2015011578A1 Dasatinib glucuronate salt and process for preparation thereof |
| 01/29/2015 | WO2015011400A1 Novel pyrrole derivatives, method for the production thereof and pharmaceutical compositions containing same |
| 01/29/2015 | WO2015011399A1 Novel phosphate derivatives, method for the production thereof, and pharmaceutical compositions containing same |
| 01/29/2015 | WO2015011397A1 Novel indolizine derivatives, method for the production thereof and pharmaceutical compositions containing same |
| 01/29/2015 | WO2015011396A1 Novel derivatives of indole and pyrrole, method for the production thereof and pharmaceutical compositions containing same |
| 01/29/2015 | WO2015011252A1 Pyrimidine-pyridinone serine/threonine kinase inhibitors |
| 01/29/2015 | WO2015011246A1 Use of flecainide as an anti-connexin agent and method for potentiating the effects of a psychotropic drug |
| 01/29/2015 | WO2015011236A1 Treatment of myelodysplastic syndrome |
| 01/29/2015 | WO2015011235A1 Volasertib in combination with azacitidine for the treatment of acute myeloid leukemia and myelodysplastic syndrome ii |
| 01/29/2015 | WO2015011234A1 Volasertib in combination with decitabine for the treatment of acute myeloid leukemia and myelodysplastic syndrome ii |
| 01/29/2015 | WO2015011164A1 New isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/29/2015 | WO2015011084A1 Substituted dihydropyrido[3,4-b]pyrazinones as dual inhibitors of bet proteins and polo-like kinases |
| 01/29/2015 | WO2015011008A1 7-azaindole derivatives as parp inhibitors |
| 01/29/2015 | WO2015010641A1 Substituted quinazolin-4-one derivatives |
| 01/29/2015 | WO2015010626A1 Therapeutically active compounds and use thereof |
| 01/29/2015 | WO2015010615A1 Recombinant trail protein and preparation method and use thereof |
| 01/29/2015 | WO2015010297A1 Therapeutically active compounds and their methods of use |
| 01/29/2015 | WO2015010293A1 Anticancer pharmaceutical composition, preparation method for same, and use thereof |
| 01/29/2015 | US20150031881 Pyrazolo pyrimidine derivatives and methods of use thereof |
| 01/29/2015 | US20150031615 Growth Hormone Releasing Peptides |
| 01/29/2015 | US20150031025 Genetic products differentially expressed in tumors and use thereof |
| 01/29/2015 | US20150030633 Application of mrna for use as a therapeutic against tumour diseases |
| 01/29/2015 | US20150030620 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 01/29/2015 | DE112013002484T5 Pteridinketon-Derivat und Anwendungen desselben als EGFR-, BLK- und FLT3-Inhibitor Pteridinketon derivative and applications thereof as EGFR, PFC and FLT3 inhibitor |
| 01/29/2015 | DE102013012432A1 Immuntherapie von Prostatakrebs Immunotherapy of Prostate Cancer |
| 01/28/2015 | EP2829609A1 Human CTLA-4 antibodies and their uses |
| 01/28/2015 | EP2829551A1 High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
| 01/28/2015 | EP2829545A1 New phosphate derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/28/2015 | EP2829539A1 New pyrrole derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/28/2015 | EP2829538A1 Polymorphic form of imatinib mesylate and process for its preparation |
| 01/28/2015 | EP2829285A1 Recombinant lentiviral vector formulation |
| 01/28/2015 | EP2829273A1 Method for producing liposome encapsulating paclitaxel monoglycoside and/or docetaxel monoglycoside |
| 01/28/2015 | EP2828280A1 Plif multimeric peptides and uses thereof |